Steward Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-132
Closed -$3K – 715
2022
Q4
$3K Buy
+132
New +$4.19K ﹤0.01% 244
2022
Q3
– Sell
-132
Closed -$4K – 137
2022
Q2
$4K Hold
132
– – ﹤0.01% 361
2022
Q1
$6K Hold
132
– – 0.01% 226
2021
Q4
$8K Buy
+132
New +$9.13K 0.01% 165

Other funds holding ARKG

Steward Financial Group's ARKG Position: Q1 2023 in Review

Steward Financial Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 132 shares — an estimated $3K sold.

Steward Financial Group first reported a position in ARKG in Q4 2021 and held it in 4 quarters. The position peaked at $8K in Q4 2021. 297 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • Steward Financial Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
  • Steward Financial Group sold 132 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $3K.
  • Steward Financial Group first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 4 quarters.
  • Steward Financial Group's ARK Genomic Revolution ETF position peaked at $8K in Q4 2021.
  • 297 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Steward Financial Group's 13F filing for Q1 2023, filed 5 May 2023.